C12N 2501/385
Of the family of the retinoic acid recptor
Official title: of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
C12N2501/385 (Of the family of the retinoic acid recptor) appears on 498 US grants and 917 published applications in this corpus.
Search patents in C12N- Granted patents
- 498
- Published applications
- 917
- Assignees
- 408
- Inventors
- 1,470
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 6 | 0 |
| 1997 | 7 | 0 |
| 1998 | 8 | 0 |
| 1999 | 3 | 0 |
| 2000 | 5 | 0 |
| 2001 | 1 | 1 |
| 2002 | 5 | 23 |
| 2003 | 7 | 16 |
| 2004 | 4 | 11 |
| 2005 | 7 | 28 |
| 2006 | 8 | 23 |
| 2007 | 5 | 21 |
| 2008 | 9 | 12 |
| 2009 | 21 | 37 |
| 2010 | 8 | 39 |
| 2011 | 9 | 31 |
| 2012 | 19 | 34 |
| 2013 | 14 | 34 |
| 2014 | 20 | 37 |
| 2015 | 26 | 36 |
| 2016 | 22 | 55 |
| 2017 | 30 | 45 |
| 2018 | 29 | 39 |
| 2019 | 43 | 56 |
| 2020 | 27 | 46 |
| 2021 | 24 | 50 |
| 2022 | 22 | 52 |
| 2023 | 22 | 36 |
| 2024 | 38 | 68 |
| 2025 | 24 | 59 |
| 2026 | 16 | 28 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for generating oligodendrocyte progenitor cells8 Sep 2026US 12,729,368 B2Trailhead Biosystems Inc.
- Oligodendrocyte progenitor cell compositions25 Aug 2026US 12,716,054 B2Asterias Biotherapeutics, Inc.
- Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene4 Aug 2026US 12,698,255 B2ImmuneBridge Inc.
- Generation of pancreatic endoderm from stem cell derived definitive endoderm21 Jul 2026US 12,686,855 B2Aspect Biosystems Ltd.
- Brain organoid containing optic vesicles generated based on H9 induction and eye-brain fusion culture method12 May 2026US 12,624,339 B2Tianjin University
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- Epithelial Stem Cells and Production and Uses thereof10 Sep 2026US 2026/0265690 A1Stemson Therapeutics Corp.
- Generation of induced neutrophils with increased activation and transmigration capabilities10 Sep 2026US 2026/0265695 A1
- Methods for the production of dendritic cells by modulating retinoid signaling6 Aug 2026US 2026/0226411 A1FUJIFILM Holdings America Corporation
- Methods and Culture Substrates for Controlled Induction of Biomimetic Neural Tissues Comprising Singular Rosette Structures30 Jul 2026US 2026/0218125 A1Wisconsin Alumni Research Foundation
Most cited
By later US patents
- Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture209US 6,800,480 B1Geron Corporation · 2004
- Mammalian neural crest stem cells206US 5,589,376 ACalifornia Institute of Technology · 1996
- Hepatocyte lineage cells derived from pluripotent stem cells175US 6,458,589 B1Geron Corporation · 2002
- Endoderm cells from human embryonic stem cells169US 7,326,572 B2Geron Corporation · 2008
- Methods of producing pancreatic hormones165US 7,534,608 B2Cythera, Inc. · 2009